Literature DB >> 24853055

Risk factors for cytomegalovirus gastrointestinal diseases in adult patients with cancer.

J-H Ko1, K R Peck, W J Lee, K Huh, J R Yoo, K Kim, S Y Cho, Y E Ha, C-I Kang, D R Chung, C W Jung, Y-H Kim, N Y Lee, K-M Kim, J-H Song.   

Abstract

Cytomegalovirus (CMV) gastrointestinal (GI) disease has been noticed frequently in cancer patients, causing abdominal pain, diarrhea, and GI bleeding. However, little is known about its actual incidence, clinical presentation, and the risk factors for its development among cancer patients. To answer these questions, we analyzed all cases that occurred during an 18-year period at our center. A case-control study was performed to identify risk factors for CMV GI disease. Electronic medical records were reviewed from individuals who were admitted and diagnosed with CMV GI disease during the period of January 1995 through March 2013 at a tertiary care center. Two CMV disease-free cancer patients were matched as controls. A total of 98 episodes of CMV GI disease were included in this study, and the overall incidence rate was 52.5 per 100,000 cancer patients, with an increasing trend throughout the study period. According to multivariate analysis, male sex, low body mass index, lymphopenia, hematological malignancy, and steroid use and red blood cell transfusion within 1 month prior to the CMV disease were identified to be independent risk factors. Among these factors, RBC transfusion showed the highest odds ratio (OR = 5.09). Male sex, low body mass index, lymphopenia, hematological malignancy, steroid use, and red blood cell transfusion within 1 month prior to the CMV disease diagnosis were independent risk factors for the development of CMV GI disease in adult patients with cancer.

Entities:  

Mesh:

Year:  2014        PMID: 24853055     DOI: 10.1007/s10096-014-2107-x

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  31 in total

1.  Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA.

Authors:  R J Whitley; M A Jacobson; D N Friedberg; G N Holland; D A Jabs; D T Dieterich; W D Hardy; M A Polis; T A Deutsch; J Feinberg; S A Spector; S Walmsley; W L Drew; W G Powderly; P D Griffiths; C A Benson; H A Kessler
Journal:  Arch Intern Med       Date:  1998-05-11

2.  Cytomegalovirus infections in unrelated cord blood transplantation in pediatric patients: incidence, risk factors, and outcomes.

Authors:  Sami Al-Hajjar; Amal Al Seraihi; Saleh Al Muhsen; Mouhab Ayas; Suliman Al Jumaah; Abdullah Al Jefri; Mohamed Shoukri; Hassan El Solh
Journal:  Hematol Oncol Stem Cell Ther       Date:  2011

3.  Early and delayed onset cytomegalovirus infection of liver transplant recipients in endemic areas.

Authors:  J M Kim; S J Kim; J-W Joh; C H D Kwon; M Shin; E Y Kim; J I Moon; G O Jung; G S Choi; S K Lee
Journal:  Transplant Proc       Date:  2010-04       Impact factor: 1.066

Review 4.  Meta-analysis of outcome of cytomegalovirus colitis in immunocompetent hosts.

Authors:  Polymnia Galiatsatos; Ian Shrier; Esther Lamoureux; Andrew Szilagyi
Journal:  Dig Dis Sci       Date:  2005-04       Impact factor: 3.199

5.  Ganciclovir for the treatment of cytomegalovirus gastroenteritis in bone marrow transplant patients. A randomized, placebo-controlled trial.

Authors:  E C Reed; J L Wolford; K J Kopecky; K E Lilleby; P S Dandliker; J L Todaro; G B McDonald; J D Meyers
Journal:  Ann Intern Med       Date:  1990-04-01       Impact factor: 25.391

Review 6.  Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments.

Authors:  Maher K Gandhi; Rajiv Khanna
Journal:  Lancet Infect Dis       Date:  2004-12       Impact factor: 25.071

7.  Cytomegalovirus infection in non-transplant patients with hematologic neoplasms: a case series.

Authors:  Hung Chang; Tzung-Chih Tang; Yu-Shin Hung; Tung-Liang Lin; Ming-Chung Kuo; Po-Nan Wang
Journal:  Chang Gung Med J       Date:  2011 Jan-Feb

8.  Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events.

Authors:  K G Saag; R Koehnke; J R Caldwell; R Brasington; L F Burmeister; B Zimmerman; J A Kohler; D E Furst
Journal:  Am J Med       Date:  1994-02       Impact factor: 4.965

9.  Cytomegalovirus infection: its incidence and management in cytomegalovirus-seropositive living related liver transplant recipients: a single-center experience.

Authors:  Manav Wadhawan; Subash Gupta; Neerav Goyal; Karisangal R Vasudevan; Kausar Makki; Reetika Dawar; Raman Sardana; Nand Lal; Ajay Kumar
Journal:  Liver Transpl       Date:  2012-12       Impact factor: 5.799

10.  The prevalence and risk factors of cytomegalovirus infection in inflammatory bowel disease in Wuhan, Central China.

Authors:  Fengming Yi; Jie Zhao; Rishi Vishal Luckheeram; Yuan Lei; Changgao Wang; Sha Huang; Lu Song; Wei Wang; Bing Xia
Journal:  Virol J       Date:  2013-02-01       Impact factor: 4.099

View more
  6 in total

1.  Massive Alimentary Tract Bleeding due to Cytomegalovirus Infection in an Elderly Patient.

Authors:  Bora Koc; Huseyin Yuce Bircan; Semsi Altaner; Ozlem Cinar; Umit Ozcelik; Alpaslan Yavuz; Ozgur Kemik
Journal:  Infect Dis Rep       Date:  2014-09-22

2.  Overt Lower Gastrointestinal Bleeding and Pseudotumor: A Rare Presentation of Cytomegalovirus Infection.

Authors:  Akanksha Agrawal; Deepanshu Jain; Sameer Siddique
Journal:  Case Rep Med       Date:  2017-10-18

3.  Impact of antiviral treatment on long-term prognosis in non-immunocompromised patients with CMV reactivation.

Authors:  Ga Eun Park; Hyun Kyun Ki; Jae-Hoon Ko
Journal:  BMC Infect Dis       Date:  2021-05-04       Impact factor: 3.090

4.  Optimal duration of antiviral treatment in patients with gastrointestinal cytomegalovirus disease at a low and high risk of relapse.

Authors:  Kyung Hwa Jung; Jiwon Jung; Min Jae Kim; Yong Pil Chong; Sang-Oh Lee; Sang-Ho Choi; Yang Soo Kim; Sung-Han Kim
Journal:  Medicine (Baltimore)       Date:  2022-01-07       Impact factor: 1.889

5.  Cytomegalovirus Diseases of the Gastrointestinal Tract.

Authors:  Pai-Jui Yeh; Ren-Chin Wu; Cheng-Tang Chiu; Ming-Wei Lai; Chien-Ming Chen; Yu-Bin Pan; Ming-Yao Su; Chia-Jung Kuo; Wey-Ran Lin; Puo-Hsien Le
Journal:  Viruses       Date:  2022-02-08       Impact factor: 5.048

6.  Cytomegalovirus Colitis Masquerading as Apple-Core Lesion after Systemic Chemotherapy in a Patient with Relapsed Acute Myeloid Leukemia.

Authors:  Jong An; Jason Brownell; Darrell Barker; Theresa Stockinger; Robert Brady; Katherine Cebe; Russell Baur
Journal:  Case Rep Oncol Med       Date:  2018-03-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.